Acorah Software Products - Accounts Production 16.4.675 false true true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 12229006 Mr Jason Yip Mr Askin Ozgur Tuncer Dr Anna Piskorz Dr Geoffrey John Macintyre Ms Kathryn Corzo Mr Hitesh Jayantilal Sanganee iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12229006 2024-03-31 12229006 2025-03-31 12229006 2024-04-01 2025-03-31 12229006 frs-core:CurrentFinancialInstruments 2025-03-31 12229006 frs-core:ComputerEquipment 2025-03-31 12229006 frs-core:ComputerEquipment 2024-04-01 2025-03-31 12229006 frs-core:ComputerEquipment 2024-03-31 12229006 frs-core:FurnitureFittings 2025-03-31 12229006 frs-core:FurnitureFittings 2024-04-01 2025-03-31 12229006 frs-core:FurnitureFittings 2024-03-31 12229006 frs-core:OtherReservesSubtotal 2025-03-31 12229006 frs-core:SharePremium 2025-03-31 12229006 frs-core:ShareCapital 2025-03-31 12229006 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 12229006 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12229006 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 12229006 frs-bus:SmallEntities 2024-04-01 2025-03-31 12229006 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12229006 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12229006 frs-bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12229006 frs-bus:OrdinaryShareClass1 2025-03-31 12229006 frs-bus:Director1 2024-04-01 2025-03-31 12229006 frs-bus:Director2 2024-04-01 2025-03-31 12229006 frs-bus:Director3 2024-04-01 2025-03-31 12229006 frs-bus:Director4 2024-04-01 2025-03-31 12229006 frs-bus:Director5 2024-04-01 2025-03-31 12229006 frs-bus:Director6 2024-04-01 2025-03-31 12229006 frs-countries:EnglandWales 2024-04-01 2025-03-31 12229006 2023-03-31 12229006 2024-03-31 12229006 2023-04-01 2024-03-31 12229006 frs-core:CurrentFinancialInstruments 2024-03-31 12229006 frs-core:OtherReservesSubtotal 2024-03-31 12229006 frs-core:SharePremium 2024-03-31 12229006 frs-core:ShareCapital 2024-03-31 12229006 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 12229006 frs-bus:OrdinaryShareClass1 2023-04-01 2024-03-31
Registered number: 12229006
Tailor Bio Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Max Accountants Ltd
Ketton Suite
The King Centre
Oakham
Rutland
LE15 7WD
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—4
Page 1
Balance Sheet
Registered number: 12229006
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 3,251 6,046
3,251 6,046
CURRENT ASSETS
Debtors 5 182,828 236,563
Cash at bank and in hand 646,067 1,219,606
828,895 1,456,169
Creditors: Amounts Falling Due Within One Year 6 (22,500 ) (33,561 )
NET CURRENT ASSETS (LIABILITIES) 806,395 1,422,608
TOTAL ASSETS LESS CURRENT LIABILITIES 809,646 1,428,654
NET ASSETS 809,646 1,428,654
CAPITAL AND RESERVES
Called up share capital 7 15 15
Share premium account 2,141,047 2,141,047
Other reserves 236,404 131,920
Profit and Loss Account (1,567,820 ) (844,328 )
SHAREHOLDERS' FUNDS 809,646 1,428,654
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Jason Yip
Director
15 July 2025
The notes on pages 2 to 4 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Tailor Bio Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12229006 . The registered office is Ketton Suite, The King Centre, Main Road, Barleythorpe, Oakham, Rutland, LE15 7WD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern. Therefore the financial statements have been prepared on a going concern basis which assumes the Company will continue in operational existence for the foreseeable future. 
The Company is involved in research and development activities and is working towards achieving a sustainable revenue generating activity. The directors have considered the basis of the financial statements and are satisfied that a combination of business growth and further investment commitments will enable the Company to meet its liabilities as they fall due.
2.3. Turnover
Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings Straight line over 4 years
Computer Equipment Straight line over 3 years
2.5. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.6. Financial Instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Basic financial assets
Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, are recognised at transaction price including transaction costs.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities.
Page 2
Page 3
2.7. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the profit / loss before taxation.
2.8. Taxation
Tax is recognised in profit or loss except that a charge is attributable to an item of income and expense recognised as other comphrehensive income or to an item recognised directly in equity is also recognised in other comphrehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.
2.9. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.10. Government Grant
Government grants are recognised in the profit and loss account in an appropriate manner that matches them with the expenditure towards which they are intended to contribute.
Grants for immediate financial support or to cover costs already incurred are recognised immediately in the profit and loss account. Grants towards general activities of the entity over a specific period are recognised in the profit and loss account over that period.
Grants towards fixed assets are recognised over the expected useful lives of the related assets and are treated as deferred income and released to the profit and loss account over the useful life of the asset concerned.
All grants in the profit and loss account are recognised when all conditions for receipt have been complied with.
2.11. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their expected useful economic lives.
If it is not possible to distinguish between the research phase and the development phase of an internal project the expenditure is treated as if it were all incurred in the research phase only.
2.12. Share Based Payments
The company operates an equity-settled, share-based compensation plan, under which the entity received services from employees as consideration for equity instruments (options) of the entity. The fair value of the employee services received is measured by reference to the estimated fair value at the grant date of equity instruments granted and is recognised as an expense over the vesting period. The estimated fair value of the option granted is calculated using the Black Scholes option pricing model. The total amount expensed is recognised over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. 
The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised. 
3. Average Number of Employees
Average number of employees, including directors, during the year was: 10 (2024: 8)
10 8
Page 3
Page 4
4. Tangible Assets
Fixtures & Fittings Computer Equipment Total
£ £ £
Cost
As at 1 April 2024 1,266 10,675 11,941
As at 31 March 2025 1,266 10,675 11,941
Depreciation
As at 1 April 2024 198 5,697 5,895
Provided during the period 316 2,479 2,795
As at 31 March 2025 514 8,176 8,690
Net Book Value
As at 31 March 2025 752 2,499 3,251
As at 1 April 2024 1,068 4,978 6,046
5. Debtors
2025 2024
£ £
Due within one year
Trade debtors - 3,967
Prepayments and accrued income 999 258
Other debtors 64,929 40,905
Corporation tax recoverable 109,619 157,219
VAT 6,380 34,214
Other taxes and social security 901 -
182,828 236,563
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 15,663 25,460
Other creditors 1,071 1,548
Accruals and deferred income 5,766 6,553
22,500 33,561
7. Share Capital
2025 2024
Allotted, called up and fully paid £ £
1,464,571 Ordinary Shares of £ 0.00001 each 15 15
On 6th January 2025, 2,449 Ordinary shares of £0.00001 each were allotted and fully paid at a price of £0.00001 per share following an exercise of EMI options.
Page 4